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Abstract: Exposure to heavy metals, including arsenic and cadmium, is associated with neurodegen-
erative disorders such as Parkinson’s disease. However, the mechanistic details of how these metals
contribute to pathogenesis are not well understood. To search for underlying mechanisms involving
α-synuclein, the protein that forms amyloids in Parkinson’s disease, we here assessed the effects
of arsenic and cadmium on α-synuclein amyloid formation in vitro and in Saccharomyces cerevisiae
(budding yeast) cells. Atomic force microscopy experiments with acetylated human α-synuclein
demonstrated that amyloid fibers formed in the presence of the metals have a different fiber pitch
compared to those formed without metals. Both metal ions become incorporated into the amyloid
fibers, and cadmium also accelerated the nucleation step in the amyloid formation process, likely
via binding to intermediate species. Fluorescence microscopy analyses of yeast cells expressing
fluorescently tagged α-synuclein demonstrated that arsenic and cadmium affected the distribution of
α-synuclein aggregates within the cells, reduced aggregate clearance, and aggravated α-synuclein
toxicity. Taken together, our in vitro data demonstrate that interactions between these two metals
and α-synuclein modulate the resulting amyloid fiber structures, which, in turn, might relate to
the observed effects in the yeast cells. Whilst our study advances our understanding of how these
metals affect α-synuclein biophysics, further in vitro characterization as well as human cell studies
are desired to fully appreciate their role in the progression of Parkinson’s disease.
Keywords: α-synuclein; amyloid formation; Parkinson’s disease; arsenic toxicity; cadmium toxicity
1. Introduction
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder
after Alzheimer’s disease (AD) and the most common movement disorder. PD is character-
ized by deterioration of motor neurons, predominantly dopaminergic neurons in substantia
nigra [1], and the presence of neuronal inclusions, known as Lewy bodies (LBs). Amyloid
fibers of the protein α-synuclein (αSyn) are the main component of LB pathology [2]. Other
than PD, αSyn inclusions have been detected in a selection of neurodegenerative diseases,
including LB variant of AD, multiple system atrophy, and dementia with Lewy bodies,
among others [2,3]. Duplication and triplication of the αSyn gene SNCA, as well as several
different missense mutations (A53T, A30P, A53E, H50Q, G51D, or E46K), have been identi-
fied in association with early onset of PD, suggesting that aberrant protein conformations
and gene overexpression accelerate disease progression [4–6]. Clearly, αSyn amyloid for-
mation is involved in PD development, but several modes of toxicity have been proposed,
including the amyloids themselves, oligomeric intermediates, as well as αSyn interactions
with for example lipid membranes [5,7]. A large part of the αSyn monomers present in a
cell at normal conditions are either bound to lipid membranes or to chaperone proteins;
thus, aberrant modulation of such interactions, and oligomer–lipid interactions, may play
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roles in the promotion of distinct features of PD, such as mitochondrial dysfunction and
oxidative stress that are found along with amyloid formation [8–10].
Amyloid fibrils are often described as having a distinct morphology with different
arrangements of twisted or parallel assemblies of thinner filaments [11]. Mature amy-
loid fibers form stepwise (Figure 1); starting with individual monomers of αSyn lumping
together to form nuclei/oligomers (primary nucleation), these oligomers can bind addi-
tional monomers resulting in long individual fibers (elongation). Additionally, the process
can be catalyzed by secondary processes; the surface of already formed fibers can work
as a catalyst for the formation of new nuclei (secondary nucleation) and long fibers can
break into shorter fragments creating new growing ends (fragmentation) [12,13]. Next,
individual fibers can associate together to form thicker (mature) fibers. The assembly of
thin fibers (often called protofilaments) into mature fibers gives rise to a periodicity in
the fibrillar structure (denoted as pitch), which can be detected and measured by atomic
force microscopy (AFM) or cryo-electron microscopy [14,15]. High resolution structures
of αSyn fibrils, recently obtained by cryo-electron microscopy and solid state nuclear
magnetic resonance (NMR) [16,17], have demonstrated that the observed pitch is created
by intertwining of protofilaments (Table S1, for reported pitch values of αSyn amyloids).
Variations in the arrangement of individual fibers relative each other, along with internal
fiber differences, give rise to different fiber morphologies. External factors such as pH,
ionic strength, and metals may affect the kinetics and pathways of αSyn amyloid formation,
as well as the internal structure, pitch, and morphology of resulting fibers [18]. NMR
data have suggested that differences in protein backbone conformation, salt bridges and
electrostatic interactions between protofilaments relate with different polymorphs of αSyn
amyloid fibers. This is important to study further as different morphologies of fibrils have





Figure 1. Schematic figure illustrating the different steps in αSyn aggregation; from monomers to oligomers via nucleation,
elongating to single fibrils (protofibrils) that combine to larger amyloid structures of different morphologies. The single
fibrils (and mature fibers) can also become the starting point for secondary processes, where both secondary nucleation and
fiber fragmentation may occur.
Exposure to heavy metals has been linked to neurodegeneration [20–22]. Binding of
metal ions to disease-associated proteins could not only affect their aggregation speed, but
also change the resulting morphology of the fibrils. The interaction of metals with αSyn
has been widely studied in recent years [23–25], and three main metal binding regions
have been identified in the protein: the N-terminus, the histidine at position 50 (H50), and
C-terminal residues. The N-terminus has been shown to be a high affinity Cu(I/II) site in
WT αSyn [26,27]; however, it is important to note that the N-terminal acetylation of the
protein blocks the Cu(II) binding capability from the N-terminal site [28]. H50 is the second
binding site involved in Cu, and possibly Zn, coordination [26,29]. Lastly, within the acidic
C-terminus, between residues 120 and 130, there are low affinity binding sites for several
metal ions (Ca, Fe, Zn, Mn, Co, Ni). The effect of metals on the αSyn amyloid formation
kinetics has also been investigated, and most metals promote its aggregation. However,
most studies have focused on physiological metal ions and have been performed with mM
concentrations of the metals in vitro.
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Humans are increasingly exposed to poisonous metals via intake of contaminated
food and water. The heavy metal cadmium (Cd) and the metalloid arsenic (As) are clearly
toxic and classified as human carcinogens [30,31]. Chronic heavy metal exposure, including
As and Cd, has been implicated in promoting the progression of certain neurodegenerative
and age-related disorders, including PD and AD [22,31–34]. However, the mechanisms by
which As and Cd affect disease processes are still not fully understood. As and Cd each
affect many processes in cells and can cause toxicity through several mechanisms, includ-
ing interference with redox metabolism and induction of oxidative stress, impaired DNA
repair, and inhibition of protein function and activity [35]. Importantly, it has been shown
that As, in form of trivalent arsenite (As(III)) [36–38], and Cd(II) [39] induce widespread
protein misfolding and aggregation in living yeast cells primarily by targeting nascent
(i.e., not yet folded) proteins. As(III) and Cd(II) inhibit refolding of chemically denatured
proteins in vitro [36,39–41], and both in vivo and in vitro data indicated that As(III)- and
Cd(II)-triggered protein aggregates formed seeds that, in a gain-of-function mechanism, in-
creased the misfolding and aggregation of other proteins [36,37,39]. Cd(II) has been shown
to promote αSyn aggregation as well as the formation of αSyn oligomers in vitro [23,42],
whilst As(III) caused a dose-dependent oligomerization of αSyn in a neuroblastoma cell
line [43]. Given the profound effects of As(III) and Cd(II) on protein misfolding and aggre-
gation as well as the suspected role of these metals in PD pathology, we here investigated
their effects on αSyn amyloid formation in vitro and its aggregation in living yeast cells.
2. Results
The αSyn variant used in this study is the biologically relevant N-terminally acety-
lated αSyn (Ac αSyn), as acetylation has been reported to be a general posttranslational
modification to the protein [44], which also occurs naturally when expressed in yeast [45].
Moreover, the N-terminus of αSyn without acetylation may engage in additional metal
binding in vitro, which is not biologically relevant and is not investigated in this study.
2.1. Effects of As(III) and Cd(II) on Ac αSyn Amyloid Fibril Morphology
We first investigated amyloid fibril morphology of αSyn amyloids after the protein
had been incubated in the presence of NaAsO2 and CdCl2. In these experiments, 50 µM Ac
αSyn was mixed with 500 µM metal ions (the concentration giving the largest change to
Ac αSyn aggregation kinetics, see below), and then incubated at 37 ◦C with agitation for
3 days at pH 7.4. The resulting fibril morphology was analyzed by atomic force microscopy
(AFM) (Figure 2). 
2 
 
  Figure 2. AFM images of amyloid fibrils formed after 90 h aggregation in pH 7.4. (A) Ac αSyn, (B) Ac αSyn + NaAsO2 1:10,
(C) Ac αSyn + CdCl2 1:10.
In all experiments, with and without metals, we observed amyloid fibrils with heights
of 6–8 nm. Visual inspection of the AFM images revealed different amyloid appearances:
straight fibrils with As(III), and curved fibrils with Cd(II), while for αSyn alone (no metal
added) we detected mostly short fibrils lumped together. Higher magnification images of
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individual fibers (Figure 3) show a twisting pattern along the fibers, which corresponds to
the fiber pitch. When Ac αSyn was aggregated without metals, we identified two sizes of
fibril pitch (found in different fibers, but both kinds present in the same sample): one with
pitch of 49 nm and the other one with 104 nm. Interestingly, for Ac αSyn amyloids formed
in the presence of As(III) or Cd(II), samples were homogeneous with only one type of fibril
morphology identified—with 71 nm pitch for As(III) and 80 nm pitch for Cd(II) (Table 1).
There are various values reported for the pitch of αSyn or Ac αSyn fibrils (without metals)
that cover the range of 40–120 nm (summarized in Table S1), and thus it appears that these
values are highly sensitive to the experimental aggregation conditions. Nevertheless, the
observed differences in αSyn amyloid pitch with and without As(III) and Cd(II) at our
conditions suggest that the metals modulate protofilament interactions within the mature
fiber.
To assess if metals are incorporated in the resulting αSyn amyloid fibers, we deter-
mined the metal concentration in the amyloids after 5 days of aggregation with 1:1 protein
to metal samples. The metal content in the fibers were indirectly determined from analysis
by inductively coupled plasma mass spectrometry (ICP-MS) of metal content in the solution
after αSyn amyloids had been removed by centrifugation. In these experiments, a reduction
of more than 50% of added metal ion concentration was detected in the remaining solution
after the fibers had been spun down (Table S2). Thus, As(III) and Cd(II) ions are being




  Figure 3. Measurement of fiber pitch in AFM images. (A,B) Ac αSyn with two distinct pitch types, (a) is showing the shorter
pitch, (b) the longer pitch, (C) Ac αSyn + NaAsO2 1:10, (D) Ac αSyn + CdCl2 1:10. The pitch was measured as the distance
between two maxima in the height curves. Heights are tracked along the indicated lines (a–d).
Table 1. Mean pitch of Ac αSyn amyloid fibrils at pH 7.4 from AFM data. Ac αSyn aggregating alone
gives rise to two types of fibers: fibrils with short pitch and fibrils with a longer pitch. The values are
a result of 50–60 measured fibers and significance calculated using Welch’s two-sided t-test (with
respect difference to the 49 nm value). Significance according to *** p < 0.001.
Fiber Type Height Mean Pitch (nm) SD
Ac αSyn
6–8 nm 49 8.8
6–8 nm 104 *** 24.9
Ac αSyn + 500 µM NaAsO2 6–8 nm 71 *** 18.9
Ac αSyn + 500 µM CdCl2 6–8 nm 80 *** 11.5
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2.2. In Vitro Ac αSyn Amyloid Formation Kinetics in the Presence of Cd(II) and As(III)
To address whether the metal ions also affect amyloid formation kinetics, we turned to
time-resolved in vitro aggregation assays. We monitored the kinetics of amyloid formation
using the Thioflavin T fluorescence (ThT) assay with 50 µM Ac αSyn as a function of
NaAsO2 and CdCl2 (1:1 to 1:10 protein-to-metal ratio) concentrations at 37 ◦C under
agitation with a glass bead at pH 7.4. The aggregation of Ac αSyn without added metals
followed a sigmoidal trace similar to that for wild type αSyn [14,46] with a lag time of
~12 h and aggregation was completed by 30 h. In the presence of Cd(II), we observed
metal concentration-dependent decrease of the lag time for Ac αSyn amyloid formation
(down to ~7 h at the highest metal concentration) (Figure 4A,C). In the case of As(III),
we detected apparent shorter lag times for 50 and 100 µM metal ions; however, the effect




  Figure 4. ThT fluorescence curves for aggregation of 50 µM Ac αSyn in the presence of (A) Cd(II)
and (B) As(III)-ions at increasing concentrations at pH 7.4. The curves in (A,B) are representative
kinetic traces based on the averages of three technical replicates. (C) Aggregation curve midpoints
(i.e. ThT fluorescence at 0.5) derived from ThT-detected kinetic data in (A,B), for various additions
of Cd(II) (light blue) and As(III) (red) to Ac αSyn. Error bars represent SD from three independent
replicates with three to four mechanical replicates each. Significance scale (different relative to the
value for protein without metals) according to: * p < 0.05, ** p < 0.01, and *** p > 0.005.
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Because these experiments may include all processes in Figure 1, we next investigated
the fibril elongation step specifically using fiber-seeded experiments to bypass primary
nucleation. Here, we followed the aggregation of Ac αSyn when fiber seeds (10 molar %)
were added to the monomeric protein (Figure S1). Monomers in the presence of seeds can
directly bind to the ends of the pre-made fibers, and indeed, what we observe from seeded
aggregation is an immediate increase in ThT intensity at time zero for all samples and the
presence or absence of metals had no effect on the kinetics. We thus conclude that neither
As(III) nor Cd(II) has any significant impact on the elongation step in the Ac αSyn amyloid
formation reaction. The overall effect on the process observed for Cd(II) in Figure 4 thus
implies that this metal mainly affects primary nucleation.
Since Cd(II) appears to affect the primary nucleation step, the metal may bind to
either αSyn monomers or early assembled intermediates. Therefore, we searched for po-
tential interactions between the metals and monomeric Ac αSyn using isothermal titration
calorimetry. Monomeric Ac αSyn was added to the reaction cell and the metal ions were
injected stepwise to the cell in up to six times molar excess. Figure S2 demonstrates a lack of
heat changes during the titration, implying no direct binding between αSyn Ac monomers
and As(III). In the case of Cd(II), heat change was observed for the first few titrations,
suggesting a possible interaction between the metal and a small fraction of contaminating
αSyn oligomers. Even if we always purify αSyn to start with pure monomer samples
in each experiment, a small fraction of protein will with time start to assemble. If Cd(II)
would bind to monomeric αSyn, we would have detected heat changes that saturated at
one to one or higher metal to protein ratios. Unfortunately, the acquired dataset was not
adequate for quantifying the ∆H and Ka values of the interaction.
2.3. As(III) and Cd(II) Affect αSyn Aggregate Distribution within Yeast Cells
To bring the acquired in vitro results to an in vivo setting, we used Saccharomyces
cerevisiae (budding yeast) as an established cellular model for αSyn biology [47]. It has
previously been shown that αSyn fused to green fluorescent protein (αSyn-GFP) expressed
in yeast first localizes to the plasma membrane (1–2 h after induction of expression, one
can see a characteristic “halo” on the cell surface), then small aggregates appear at the
plasma membrane and, upon an extended expression, large aggregates are visible in the
interior of the cell [48]. We expressed αSyn-GFP from the inducible GAL1-promotor in
living yeast cells and quantified aggregates of αSyn as fluorescent foci associated with the
cell surface/plasma membrane and in the interior of the cell. We counted cells that had 1–2
aggregates/cell and those with ≥3 aggregates/cell in the absence and presence of As(III)
and Cd(II). The metal concentrations used in the yeast assays (500 µM NaAsO2 and 50 µM
CdCl2) do not affect cell viability, aggregate dissolution, or clearance mechanism during
the experimental time course [36,39].
In the absence of metals, the total fraction of cells having αSyn aggregates increased
after induction of αSyn-GFP expression, and the proportion of cells with ≥3 αSyn-GFP
aggregates/cell increased during the course of the experiment (Figure 5). The kinetics of
aggregate formation and the total αSyn aggregation level was not significantly affected in
cells exposed to As(III) or Cd(II); however, the distribution of cells with 1–2 aggregates/cell
and ≥3 aggregates/cell was affected. In the absence of metals, most cells (~90%) had ≥3
αSyn-GFP aggregates/cell at the 5 h time point. In contrast, exposure to As(III) and Cd(II)
resulted in a larger proportion of cells with 1–2 aggregates/cell; the proportion of cells
with 1–2 aggregates/cell was ~10% in unexposed cells whilst it was ~45% and ~35% in
As(III) and Cd(II) exposed cells, respectively (Figure 5A,B). We also noted that As(III) and
Cd(II) exposed cells retained substantially more αSyn-GFP in or near the plasma membrane
than unexposed cells (Figure 6; red arrows). Approximately 37% (±6%) of un-stressed
cells containing aggregates had a visible “halo” of αSyn-GFP in the plasma membrane,
cells exposed to Cd(II) had 44% (±4%), compared to the cells exposed to As(III) that had
73% (±2.3%) of aggregate-containing cells having plasma membrane-associated αSyn-GFP.
Hence, As(III) and Cd(II) affect αSyn-GFP localization in vivo.




  Figure 5. (A) In vivo aggregation of αSyn in metal exposed yeast cells. The αSyn-GFP localization was monitored in
wild-type cells before and after 1, 3, and 5 h of exposure to either 500 µM NaAsO2 or 50 µM CdCl2. The fractions of cells
containing aggregates (either 1–2 or ≥3 aggregates/cell) were determined by visual inspection of approx. 300 cells per
condition. The error bars represent SD from three independent biological replicates. Significance is calculated with the
unexposed cells as reference, (un-paired two-tailed student’s t-test, blue: ≥3 aggregates/cell; * p < 0.05). (B) Percentage of
cells with 1–2 aggregates/cell out of the total percentage of cells with αSyn-GFP inclusions. Significance here refers to 1–2
aggregates/cell, red: 500 µM NaAsO2; light blue: 50 µM CdCl2, with * p < 0.05. 
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  Figure 6. Fluorescent microscopy images showing αSyn-GFP in the cells in the absence of metal and after 5 h of metal stress.
Cells with membrane-associated αSyn-GFP are indicated with red arrows. (A) αSyn-GFP cells without metal exposure.
(B) αSyn-GFP cells + 50 µM CdCl2. (C) αSyn-GFP + 500 µM NaAsO2. The GFP-foci/aggregates were determined by visual
inspection of 200 to 300 cells per condition and time point. Representative images are shown.
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2.4. Impact of As(III) and Cd(II) on Newly Synthesized αSyn, αSyn Clearance, and αSyn Toxicity
in Yeast Cells
We next examined whether As(III) and/or Cd(II) targets nascent (polypeptides made
by ribosomes after metal additions) or mature (polypeptides synthesized prior to metal
additions) αSyn. For this, we treated cells expressing αSyn-GFP with As(III) or Cd(II) and
simultaneously added the protein synthesis inhibitor cycloheximide (CHX), and monitored
the number of αSyn-GFP aggregates over time. CHX addition inhibited αSyn aggregation
in equal measure for untreated and metal exposed cells (Figure 7), suggesting that the
metals primarily affect nascent αSyn and not protein already present in the cells. 
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  Figure 7. (A) In vivo aggregation of αSyn-GFP in the presence of 0.1 mg/mL of the protein synthesis inhibitor cycloheximide
(CHX). αSyn-GFP foci localization was monitored after 0, 1, 3, and 5 h of exposure to either NaAsO2 or CdCl2. The fractions
of cells containing aggregates (either 1–2 or ≥3 aggregates/cell) were determined by visual inspection of approx. 300 cells
per condition. The error bars represent SD from three independent biological replicates. Significance is calculated with
the untreated control as reference (un-paired two-tailed student’s t-test against CHX-treated cells, black: total fraction of
cells with aggregates; blue: ≥3 aggregates/cell; * p < 0.05). (B) Percentage of 1–2 aggregates out of the total percentage of
cells with αSyn-GFP inclusions when CHX is present in the cells. Significance here refers to 1–2 aggregates/cell, light blue:
50 µM CdCl2, with * p < 0.05.
Clearance of αSyn-GFP aggregates involves internalization through endocytosis and
subsequent degradation through autophagy and vacuolar degradation [49,50]. Given the
observed effects of As(III) and Cd(II) on αSyn-GFP aggregate localization/distribution
(Figures 6 and 7), we next asked if these metals affect αSyn clearance. For this, we first
induced the expression of αSyn-GFP from the GAL1 promoter during 5 h, then turned
off αSyn-GFP expression and quantified aggregate levels as above. As shown in Figure 8,
As(III) appears to inhibit αSyn aggregate clearance in a concentration-dependent manner.
Likewise, Cd(II) at the concentration used (higher concentrations are too toxic to cells and
could not be tested here) affected αSyn clearance.
αSyn has been shown to be toxic to yeast cells [48], and we next addressed whether
yeast expressing αSyn-GFP are more susceptible to metal stress as well. Yeast cells contain-
ing αSyn-GFP were grown overnight in a glucose medium (αSyn-GFP expression off) and
then spotted onto agar plates with galactose (αSyn-GFP expression on) or without galactose
(αSyn-GFP expression off) as well as different concentrations of As(III) and Cd(II). Cells
expressing αSyn were somewhat more sensitive to both As(III) and Cd(II) than cells with
the corresponding empty plasmid or cells in which αSyn-GFP expression is off (Figure 9).
Thus, the presence of metals aggravates αSyn toxicity in yeast.




  Figure 8. Clearance of αSyn-GFP aggregates (1–2 aggregates, or ≥3) in vivo over 3 h in the presence or absence of NaAsO2
or CdCl2. αSyn-GFP expression was induced for 5 h (Gal-induction), then induction was stopped (addition of glucose) and
aggregate clearance monitored in the absence and presence of (A) 50 µM CdCl2 and (B) 250 µM, 500 µM, and 1 mM NaAsO2.
The percentage of cells containing aggregates was determined by visual inspection of approx. 300 cells per condition and
time point. The error bars represent SD from three independent biological replicates. * p < 0.05 and ** p < 0.01 compared
with the untreated control (un-paired two-tailed student’s t-test, black: total fraction of cells with aggregates; (A) pink or (B)




  Figure 9. Yeast growth assays. BY4741 cells were transformed with an empty vector or a plasmid expressing αSyn-GFP.
Cells were grown overnight in YNB-URA with 2% glucose as carbon source. Cell cultures were adjusted to the same OD,
serially diluted, and spotted into YNB-URA with 2% glucose or 2% galactose as carbon source and the indicated As(III)
and Cd(II) concentrations. Plates were incubated at 30 ◦C for 3 days. Images shown are representative of three biological
replicates.
3. Discussion
The in vitro data suggested that As(III) and Cd(II) interaction with αSyn changes the
resulting structures of the amyloid fibers, at least with respect to the fiber pitch. Our AFM
clearly showed that both As(III) and Cd(II) change the fiber structural characteristics of Ac
αSyn when the metals were added in a 10-fold molar excess. The change in pitch values
and the fact that the samples are more homogenous (containing one type of fiber) suggest
that amyloid formation in the presence of these metals affect fiber morphology (at least with
respect to pitch and heterogeneity). Our ICP-MS results further indicate that both As(III)
and Cd(II) are present in the fibers; this can occur either by the metals becoming bound to
the surface of protofibrils or by being incorporated into the protofibrils at earlier stages of
the aggregation process, giving rise to the altered mature fibril arrangement. Binding of
metals to mature fibers has been reported earlier in a study by Dearborn et al. [51] where
dense threads of metal ions on the surface of αSyn fibers were identified using electron
microscopy. Additionally, the pitch for the αSyn fibers in that study (77 nm) is similar to
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what we have found for the As(III) and Cd(II) containing conditions here. Interestingly,
a decrease in the fiber pitch values has been reported for various pathological αSyn core
mutants [15,52,53] and also upon truncation of the αSyn C-terminal domain [54] (see
Table S1).
Based on the similarity with these studies, As(III) and Cd(II) might interact with either
the core or the C-terminus of αSyn. For Cd(II), a possible candidate site for interaction is
histidine 50 located in the amyloid core region. H50 is linked to the pathological mutation
H50Q and coordination of Cd(II) to this site might affect the protofilament-surface thereby
affecting the assembly and thus periodicity of mature fibers. As(III) preferentially binds to
cysteine residues but non-thiol binding (e.g., lysine) might also occur [55]. The latter likely
occurs in the case of αSyn, which lacks cysteine. Both As(III) and Cd(II) might also bind in
the C-terminal domain of αSyn where weak binding sites (negatively charged residues)
for various cationic metals have been identified [25]. It is unclear how the conformation of
the C-terminal domain is affecting the overall fiber morphology, but as mentioned above,
the removal of the C-terminal domain results in fibers with shorter pitch. Taken together,
although the binding sites are not identified, binding of these metals to αSyn affect the
periodicity of mature fibers.
The aggregation assays further support the notion that Cd(II) interacts with Ac αSyn:
the decrease in lag time and midpoint would imply that the primary nucleation step is
promoted by the metal since the critical concentration of fibril forming nuclei is reached
at an earlier time point. Notably, we observed a statistically significant decrease in lag
time and midpoint upon addition of 50 M CdCl2, which is the same concentration as
used in the in vivo experiments. This effect implies that the metal ion binds during early
stages of amyloid formation, which can be achieved either by the metal binding to protein
monomers and promoting oligomer formation, or by binding to oligomers and stabilizing
them in their process towards amyloid fibers. The results from the ITC does not support
monomer interactions but instead imply that Cd(II) interacts with oligomeric Ac αSyn
species. Since the ITC is performed under constant stirring, a small amount of oligomers
may form in the sample and they may bind the titrated Cd(II) ions and give rise to the
initial heat changes. In terms of As(III), it did not affect have a significant effect on amyloid
formation kinetics, but it may still bind to αSyn at any stage of the aggregation process or
to the fibers after their formation (but before maturation to affect fiber pitch).
Our in vivo assays show that As(III) and Cd(II) affect αSyn-GFP localization, clear-
ance, and toxicity in yeast cells. However, the mechanism(s) by which metals impact αSyn
biology remain to be understood. It is possible that metal interactions with αSyn and
the resulting effects on the amyloid fiber morphology seen in vitro, underlie the observed
effects (such as the number of aggregates, localization, clearance, and toxicity) when αSyn
was expressed in yeast cells. Metals may interfere with protein function by direct binding
to functional groups, by displacing essential metal ions in metalloproteins, or by catalyzing
oxidation of amino acid side chains [33,56]. Alternatively, As(III) and Cd(II) could disturb
other processes in vivo that in turn indirectly affect αSyn biology and thereby cell toxic-
ity. For example, metal inhibition of endocytosis, autophagy, and vacuolar degradation
processes might impact αSyn clearance and toxicity. Similarly, both As(III) and Cd(II)
induce widespread protein aggregation in cells [36,39], which might shift the available
pool of molecular chaperones away from αSyn [57] to other misfolded and aggregated
proteins. This, in turn, might result in a decreased capacity to protect the cell against αSyn
aggregation and toxicity. Finally, As(III) and Cd(II) exposure can induce oxidative stress
and disrupt ATP generation [22], which in turn might also impact αSyn biology.
Different forms of αSyn aggregate species exhibit different toxicities in vivo, with more
and more evidence suggesting that oligomers are more toxic than fully formed amyloid
fibers [19]. We observed that more αSyn is retained in the plasma membrane during
As(III) and Cd(II) exposure, and hypothesize that metal binding to αSyn might cause the
protein to stay longer in the membrane as monomers and oligomers, thereby contributing
to toxicity during long-term metal exposure. Future in vitro studies should investigate
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the effects of As(III) and Cd(II) on αSyn aggregation in the presence of lipid vesicles to
mimic membrane interactions. Metals may also affect the size and properties of aggregates.
Indeed, we recently showed that Cd(II)-induced luciferase aggregates are smaller than
heat-induced luciferase aggregates and that Cd(II)-aggregated proteins form seeds that
increase the misfolding of other proteins [39]. It will be important to determine whether
metals directly interact with αSyn in vivo, and whether such interactions contribute to
the here observed alterations in toxicity. In any case, metal interaction is likely to occur
primarily with nascent αSyn since inhibition of protein synthesis by CHX prevented αSyn
aggregation in vivo.
To sum up, chronic arsenic and cadmium exposure is associated with a variety
of neurodegenerative disorders caused by aberrant protein folding including PD and
AD [31–33,58,59]. Our data presented here indicates that As(II) and Cd(II) interactions
with αSyn intermediate assemblies change the resulting conformation of the amyloid fibers
in vitro and that As(III) and Cd(II) affect αSyn biology and toxicity in vivo (see summary
Figure 10). The effects of As(III) and Cd(II) on protein misfolding in general and on αSyn
conformation in particular, might explain how these metals contribute to disease. Nev-
ertheless, further in vitro characterization as well as human cell studies are needed to





Figure 10. Illustration of the possible pathways in αSyn aggregation (A) and processes of αSyn in yeast (B) that might be
affected by As(III) and Cd(II). (A) In vitro addition of Cd(II) accelerates the primary nucleation step; possible changes to the
internal structure of single fibrils result in morphological changes to the mature amyloid fibers. (B) (1–2) the synthesis of
αSyn and its interaction with plasma membranes, (3) the localization and relocation of aggregates, and (4) clearance of αSyn
aggregates.
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4. Methods
4.1. Expression and Purification of αSyn
The protein Ac αSyn was expressed and purified as previously described [46].
4.2. ThT Aggregation Assay
The amyloid formation assays were conducted using 96-well half-area transparent
bottom plates (CLS3881; Corning, Corning, NY, USA), with 2 mm glass bead in each well in
a plate reader-incubator instrument (Fluostar Optima; BMG Labtech, Ortenberg, Germany).
To prevent contamination and evaporation, the plates were sealed with transparent tape.
Measurements were performed in TBS (0.05 M Tris-HCl buffer, pH 7.4 with 0.15 M NaCl,
Sigma-Aldrich, St. Louis, MO, USA) in the presence of 20 µM Thioflavin T (ThT; T3516;
Sigma-Aldrich, St. Louis, MO, USA) at 37 ◦C using 5 min 200 rpm agitation in the beginning
of each 20 min measurement cycle. Fluorescence was measured from the bottom of the
plate. The metal salts sodium arsenite (NaAsO2) and cadmium chloride (CdCl2) was added
to the samples at the indicated concentrations. The protein was gel filtered before each
experiment to ensure that the starting product was monomers at a concentration of 50 µM.
The samples were incubated for 70–90 h with measurement every 20 min; ThT was exited at
440 nm and emission recorded at 480 nm. For the seeded aggregation, seeds were obtained
by incubating Ac αSyn under the conditions described above. After the aggregation was
complete, the samples were sonicated for 10 s using a probe sonicator (stepped microtip
and Ultrasonic Processor Sonics Vibra-Cell; Sonics & Materials, Newtown, CT, USA) at an
amplitude of 20%, and an alternating cycle of 5 s on and 5 s off. The resulting short fibrils
were added to monomeric protein in the seeding experiments where the measurement
procedure did not include addition of glass beads and agitation of the samples in order to
avoid breaking of the growing fibers. All experiments were performed with 4–5 replicates
and repeated three independent times.
4.3. AFM
Samples from the ThT aggregation assays at 90 h were diluted 10 times in MilliQ
water and deposited onto freshly cleaved mica. After 15 min, the mica samples were rinsed
twice with MilliQ water then dried completely under a gentle stream of nitrogen. The
images were captured using an NTEGRA Prima setup (NT-MDT, Moscow, Russia) at a
resonance frequency around 180 kHz, using a gold-coated single crystal silicon cantilever
(NSG01, spring constant of ~5.1 N/m; NT-MDT, Moscow, Russia). Images of 512 pixels
were captured at a scan rate ranging from 0.3–0.5 Hz, scanning a minimum of four 50
µm × 50 µm areas in each sample. Images were analyzed using WSxM 5.0 software [60],
with around 60 fibers measured per condition. The images shown in this article are
representative for each condition.
4.4. ITC
Measurements were performed using a Microcal iTC200 calorimeter (Malvern In-
struments, Malvern, UK), with a sample cell volume of 206 µL and titration syringe of
40 µL. Prior to the experiments Ac αSyn was gel filtered on BioRad Enrich 70 column using
TBS as running buffer and the metal salts NaAsO2 and CdCl2 were dissolved in the same
buffer. The temperature was set to 25 ◦C, initial delay 120 s, reference power 6 µCal/s, with
750 rpm stirring, and high feedback/gain was used. Titrations of 2 µL of As(III) or Cd(II)
salts (up to 6 times molar excess) to Ac αSyn (50 µM) were performed with 4 s duration,
spacing of 180 s, and filtering time of 2 s. For all titration series, a first aliquot of 0.4 µL
was injected but not included in the analysis. The heat change during the titration was
registered in real time, and peaks were integrated to obtain the heat change per mole of
injectant, using the Origin software (OriginLab, Northampton, MA, USA) supplied with
the instrument.
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4.5. Metal Concentration in Fibers
The concentration of metal bound in fibers was measured by aggregating the protein
with the metal salts NaAsO2 and CdCl2, at a protein-to-metal ratio of 1:1, over three days
at 37 ◦C and 200 rpm, with a 2 mm glass bead in the sample tubes. The samples were spun
down at 20 k rpm for 25 min and the supernatant collected for analysis. The content of
As(III) and Cd(II) in the samples was measured using an inductively coupled plasma-mass
spectrometry (ICP-MS) as previously described [38].
4.6. Yeast Strains and Growth Conditions
The S. cerevisiae strain used in this study was BY4741 WT (MATa his3∆1 leu2∆0 met15∆0
ura3∆0). Plasmids used were the following: pRS426-GAL [61] and pRS426-GAL-αSynWT-
GFP [47]. Cells were cultivated in minimal YNB (yeast nitrogen base) medium lacking
appropriate amino acid for selection, and 2% glucose, raffinose or galactose as carbon
source. Stock solutions of sodium arsenite (NaAsO2), cadmium chloride (CdCl2), and
cycloheximide (CHX) (all from Sigma-Aldrich, St. Louis, MO, USA) were added directly
to the growth medium for the florescence microscopy and growth assays at the indicated
concentrations.
4.7. Fluorescence Microscopy
To follow the aggregation of αSyn in the cells, transformants containing αSyn-GFP
(GAL-promotor) were grown in YNB medium lacking uracil (YNB-Ura; Formedium, Hun-
stanton, UK) and 2% glucose overnight. The culture was then diluted to an optical density
(OD600nm) of 0.2 and the medium changed to YNB-Ura with 2% raffinose, and grown to an
OD of 0.5–0.6 overnight. To promote expression of αSyn-GFP, the media was changed to
contain 2% galactose, and the culture induced for 2 h to ensure that the cells had started to
express measurable levels of αSyn-GFP before sample collection.
4.8. Growth Assays on Plate
Cells were grown in YNB lacking uracil (YNB-Ura; Formedium, Hunstanton, UK)
overnight. The OD of the cultures was adjusted to the same value (0.8–1), serially diluted,
and spotted onto YNB-Ura agar plates with 2% glucose or 2% galactose as carbon source,
containing the indicated As(III) and Cd(II) concentrations. Plates were incubated at 30 ◦C
and monitored for 2–3 days. Representative pictures are shown from at least 3 biological
repetitions.
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